A 12-Week, Phase 2 Study of Gemcabene in Hypercholesterolemia Patients on Stable Moderate and High-Intensity Statins (ROYAL-1)
A 12-Week, Phase 2 Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy, Safety and Tolerability of Gemcabene in Subjects With Hypercholesterolemia Not Adequately Controlled on High-Intensity or Moderate-Intensity Stable Statin Therapy
Sponsor: NeuroBo Pharmaceuticals Inc.
A PHASE2 clinical study on Hypercholesteremia, this trial is completed. The trial is conducted by NeuroBo Pharmaceuticals Inc. and has accumulated 9 data snapshots since 2016. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Jul 2020 — Jan 2021 [monthly]
Completed PHASE2
-
Apr 2020 — Jul 2020 [monthly]
Completed PHASE2
▶ Show 4 earlier versions
-
Jun 2018 — Apr 2020 [monthly]
Completed PHASE2
-
Sep 2017 — Jun 2018 [monthly]
Completed PHASE2
Status: Recruiting → Completed
-
Feb 2017 — Sep 2017 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- NeuroBo Pharmaceuticals Inc.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Atlantis, United States , Beverly Hills, United States , Birmingham, United States , Boca Raton, United States , Cincinnati, United States , Evanston, United States , Houston, United States , Huntington Park, United States , Indianapolis, United States , Jacksonville, United States and 12 more locations